Amid a wave of optimism in financial markets, investors can relax about the expected profit rebound in 2021. They might worry more about 2022. Read More WSJ.com: Markets...
Pfizer and Moderna might be first with vaccines, but others could still grab market share. Read More WSJ.com: Markets...
New legislation that is likely to force some Chinese companies off U.S. exchanges will accelerate a migration under way since last year. Read More WSJ.com: Markets...
U.S. stock futures wavered ahead of a full slate of economic data as investors keep an eye on a potential exile for Alibaba and other Chinese stocks Read More WSJ.com: Markets...
Its platform design could help the company stay in the limelight once the Covid-19 pandemic subsides. Read More WSJ.com: Markets...
People don’t need flight upgrades, airport lounges and other perks of airline cards in a pandemic. Airlines and banks are scrambling to keep the cards at the top of customers’ wallets. Read More WSJ.com: Markets...
Weekly jobless claims are expected to have steadied after recent increases as Covid-19 cases continue to spread. Read More WSJ.com: Markets...
More employers are reversing course as their businesses rebound and a Covid-19 vaccine is on the horizon. Read More WSJ.com: Markets...
OPEC and its allies are closing in on an agreement to modestly boost their collective oil output by as much as 500,000 barrels a day starting next month, people familiar with the matter said. Read More WSJ.com: Markets...
U.S. action against Chinese companies on audit grounds likely won’t do the damage that it would have a decade ago. Read More WSJ.com: Markets...